Power Corp of Canada stock forecast
Power Corp of Canada (PCR) Stock Forecast & Price Target
PCR Analyst Ratings
PCR Stock 12 Month Forecast
Average Price Target
€67.72▲(13.51% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Graham Ryding | TD Cowen | €64.05→€67.86 | buy | 13.74%Upside | Upgraded | 11/13/26 | ||
| Scott Fletcher | CIBC | €64.05→€67.22 | hold | 12.68%Upside | Reiterated | 11/13/26 | ||
| Bart Dziarski | RBC Capital | €65.32→€72.93 | buy | 22.24%Upside | Reiterated | 11/13/26 | ||
| Desjardins | €65.95→€66.59 | buy | 11.61%Upside | Reiterated | 11/13/26 | |||
| Tom Mackinnon | BMO Capital | €62.78→€62.15 | hold | 4.17%Upside | Reiterated | 11/09/26 | ||
| Phil Hardie | Scotiabank | €67.86→€68.17 | buy | 14.27%Upside | Reiterated | 10/28/26 | ||
| Veritas Investment Research | €69.12 | buy | 15.86%Upside | Initiated | 10/21/26 | |||
| John Aiken | Jefferies | €72.30 | buy | 21.18%Upside | Upgraded | 08/04/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Graham RydingTD Cowen | BuyUpgraded€64.05→€67.86 | 11/13/26 | 13.74%Upside | ||
| Scott FletcherCIBC | HoldReiterated€64.05→€67.22 | 11/13/26 | 12.68%Upside | ||
| Bart DziarskiRBC Capital | BuyReiterated€65.32→€72.93 | 11/13/26 | 22.24%Upside | ||
| BuyReiterated€65.95→€66.59 | 11/13/26 | 11.61%Upside | |||
| Tom MackinnonBMO Capital | HoldReiterated€62.78→€62.15 | 11/09/26 | 4.17%Upside | ||
| Phil HardieScotiabank | BuyReiterated€67.86→€68.17 | 10/28/26 | 14.27%Upside | ||
| BuyInitiated€69.12 | 10/21/26 | 15.86%Upside | |||
| John AikenJefferies | BuyUpgraded€72.30 | 08/04/26 | 21.18%Upside |
Best Analysts Covering Power Corp of Canada
Copying Graham Ryding's trades and holding each position for 3 Months would result in 82.61% of your transactions generating a profit, with an average return of +9.20% per trade.
Copying Douglas Young's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +34.98% per trade.
Copying Douglas Young's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +43.06% per trade.
PCR Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 6 | 6 | 6 | 6 | 7 |
| Hold | 6 | 2 | 2 | 1 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 8 | 8 | 7 | 10 |
In the current month, PCR has received 7 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. PCR average Analyst price target in the past 3 months is 67.72.
PCR Financial Forecast
PCR Earnings Forecast
Next quarter’s earnings estimate for PCR is EUR 1.03 with a range of EUR 0.99 to EUR 1.06. The previous quarter’s EPS was EUR 0.97. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
PCR Sales Forecast
Next quarter’s sales forecast for PCR is EUR 3.21B with a range of EUR 3.21B to EUR 3.21B. The previous quarter’s sales results were EUR 6.12B. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.

